<DOC>
	<DOC>NCT00994409</DOC>
	<brief_summary>The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.</brief_summary>
	<brief_title>Patient Satisfaction in Stroke Patients</brief_title>
	<detailed_description>Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>all patients eligible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Stroke</keyword>
</DOC>